SELECT trial
A major clinical trial studying cardiovascular outcomes (Semaglutide and Cardiovascular Outcomes in people with Obesity) examining heart attack, stroke, and cardiovascular death in people with obesity treated with GLP-1 receptor agonists
As defined in GLP-1 Aren’t Just Weight Loss Drugs: A Provocative Discovery
Where it comes up · 1
Most important claims · 1 of 1Search all claims for “SELECT trial” →
- The SELECT trial (studying cardiovascular outcomes in people with obesity) found that the extent of weight loss from GLP-1 therapy did not correlate with the drug's effects in reducing heart attack, stroke, and cardiovascular death, indicating benefits independent of weight loss magnitude.GLP-1 Aren’t Just Weight Loss Drugs: A Provocative Discovery